Literature DB >> 11384872

Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase.

V Luu-The1.   

Abstract

Androgens and estrogens are not only synthesized in the gonads but also in peripheral target tissues. Accordingly, recent molecular cloning has allowed us to identify multiple types of 17beta-hydroxysteroid dehydrogenases (17beta-HSD), the key and exclusive enzymes involved in the formation and inactivation of sex steroids. However, only one form, namely, type 3 17beta-HSD, is responsible for pseudohermaphroditism in deficient boys. To date, seven human 17beta-HSDs have been isolated and characterized. Although they catalyze substrates having a similar structure, 17beta-HSDs have very low homology. In intact cells in culture, these enzymes catalyze the reaction in a unidirectional way - types 1, 3, 5 and 7 catalyze the reductive reaction, while types 2, 4 and 8 catalyze the oxidative reaction. It is noteworthy that rat type 6 17beta-HSD also catalyzes the reaction in the oxidative direction. In this report, we analyze the different characteristics of the multiple types of human 17beta-HSD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384872     DOI: 10.1016/s0960-0760(00)00155-2

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  27 in total

1.  Berries and ellagic acid prevent estrogen-induced mammary tumorigenesis by modulating enzymes of estrogen metabolism.

Authors:  Harini S Aiyer; Ramesh C Gupta
Journal:  Cancer Prev Res (Phila)       Date:  2010-05-25

Review 2.  Association between HSD17B1 rs605059 polymorphisms and the risk of uterine diseases: a systemic review and meta-analysis.

Authors:  Xiyan Mu; Xue Du; Kui Yao; Jitong Zhao; Ce Bian; Qiao Wang; Hongwei Ma; Tao Yi; Yang Wu; Xia Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  Early onset of puberty and early ovarian failure in CYP7B1 knockout mice.

Authors:  Yoko Omoto; Richard Lathe; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 4.  Regulation of 17β-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage.

Authors:  Mirja Rotinen; Joaquín Villar; Ignacio Encío
Journal:  J Physiol Biochem       Date:  2012-02-29       Impact factor: 4.158

5.  Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk.

Authors:  Stalo Karageorgi; Monica McGrath; I-Min Lee; Julie Buring; Peter Kraft; Immaculata De Vivo
Journal:  Gynecol Oncol       Date:  2010-12-03       Impact factor: 5.482

6.  Estrogen receptor alpha and imprinting of the neonatal mouse ventral prostate by estrogen.

Authors:  Yoko Omoto; Otabek Imamov; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

7.  17β-hydroxysteroid dehydrogenase type Gene 1937 A > G Polymorphism as a Risk Factor for Cervical Cancer Progression in the Polish Population.

Authors:  Anna Lutkowska; Andrzej Roszak; Pawel P Jagodziński
Journal:  Pathol Oncol Res       Date:  2016-08-29       Impact factor: 3.201

8.  Molecular cloning and expression of 17β-hydroxysteroid dehydrogenase type 2 gene in Hu sheep.

Authors:  Chang Long Wang; Shi Jia Ying; Zi Yu Wang; Hui Jun Xing; Li Zhong Wang; Dong Yang He; Shen Hua Xiao; Feng Wang
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

9.  Species used for drug testing reveal different inhibition susceptibility for 17beta-hydroxysteroid dehydrogenase type 1.

Authors:  Gabriele Möller; Bettina Husen; Dorota Kowalik; Leena Hirvelä; Dariusz Plewczynski; Leszek Rychlewski; Josef Messinger; Hubert Thole; Jerzy Adamski
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

10.  Expression in E. coli and tissue distribution of the human homologue of the mouse Ke 6 gene, 17beta-hydroxysteroid dehydrogenase type 8.

Authors:  Shuji Ohno; Kouki Nishikawa; Yoko Honda; Shizuo Nakajin
Journal:  Mol Cell Biochem       Date:  2007-11-03       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.